About Cardiome Pharma Corp
Cardiome Pharma Corp is a biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of cardiovascular diseases. The company is dedicated to improving the lives of patients with heart conditions through the development of novel drugs and therapies. Cardiome's lead product, Brinavess (vernakalant), is an intravenous antiarrhythmic agent used for the rapid conversion of atrial fibrillation to sinus rhythm. The company also engages in research and development activities to expand its product pipeline and enhance its therapeutic offerings. With a commitment to scientific excellence and patient care, Cardiome aims to address unmet medical needs in the cardiovascular space.
Company facts
- Industry
- Biopharmaceutical
- Sub-industries
- Cardiovascular, Pharmaceuticals, Biotechnology
- Location
- Vancouver, Canada
- Employees
- 1–10
- Revenue (USD)
- <1M
Products and services
Open Cardiome Pharma Corp in GlobalDeal Is this your company? Update the details for free
More Biopharmaceutical companies in Canada
- Culmina Pharma
Culmina Pharma is a biopharmaceutical company focused on the development and commercialization of innovative therapies for patients with unmet medical needs. The company is… - Crescendo Pharma
Crescendo Pharma is a biopharmaceutical company focused on developing innovative therapies for patients with unmet medical needs. The company specializes in the research and… - Aeterna Zentaris Inc.
Aeterna Zentaris Inc. is a biopharmaceutical company focused on developing and commercializing novel therapeutics for the treatment of cancer and endocrine disorders. The company… - Aurinia Pharmaceuticals Inc.
Aurinia Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on the development of innovative therapies for the treatment of autoimmune diseases. The…